Please ensure Javascript is enabled for purposes of website accessibility

3 Worst-Performing Stocks in March

By Rich Duprey - Apr 1, 2017 at 8:12AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

These three stocks had the worst month of March than any other stock on the market.

It's said that if March comes in like a lion, it goes out like a lamb, and vice versa. For at least two of the stocks below, March looked like it was off to a roaring start, but now as it ends, it looks like all three being led to a slaughter.

Let's take a closer look at why NantHealth (NH -2.42%), Nutanix (NTNX 1.14%), and Tellurian (TELL -3.34%) were the three worst-performing stocks on the market in March.

NantHealth chairman and CEO Dr. Patrick Soon-Shiung meets with Pope Francis

Image source: NantHealth. 

NantHealth

NantHealth can't seem to escape allegations of fraud, which have dogged it for years and once delayed its IPO, which finally occurred last June. The latest charge of malfeasance is related to its chairman and CEO Dr. Patrick Soon-Shiong making a charitable donation to the University of Utah for the purpose of pursuing genomics analysis, but STAT News, which broke the story, reported that he structured the gift in such a way that it all but assured only NantHealth could receive the money. Fortune magazine quoted a tax expert as saying, "I think that this transaction was deliberately structured to attempt to disguise self-dealing."

Soon-Shiong has been accused of engaging in financial trickery before. Two years ago, two former employees said NantHealth was "engaged in a multitude of fraudulent activities," including using Soon-Shiong's charitable foundation to defraud the government by funneling money from the Centers for Medicare and Medicaid Services to make purchases of NantHealth equipment.

NantHealth has largely been on a downward slide since its IPO, but it has lost an additional 33% of its value in March. Needless to say, with numerous lawsuits being filed against it for fraud, investors would be wise to give this stock a wide berth.

Two men walking in Nutanix' data center

Image source: Nutanix. 

Nutanix

Another recent IPO, this one last September, storage technology start-up Nutanix seemed to have a bright future in challenging the stalwarts of the industry like Cisco (CSCO -0.62%), EMC (EMC), Hewlett-Packard Enterprise (HPE -1.00%), and NetApp, because it essentially combines servers, virtualization, and storage in one device, or what's called hyperconvergence. That would supposedly eliminate, for example, the need for a company to purchase EMC storage gear.

The launch of a tech IPO certainly got the market's attention, and though it was priced at $16 a share at the offering, it closed that day at $37 and went on to peak at almost $47 a stub. It's been a long way down since, and it has lost almost 38% of its value in March alone.

The problem is, competition is much more intense than believed, and though it reported earnings at the start of the month that exceeded analyst expectations, its guidance was below forecasts, and because of all of the chips it needs to source to create its all-in-one boxes, margins look like they'll be fairly compressed.

Hewlett-Packard Enterprise's purchase of Nutanix competitor Simplivity for $650 million will put extra pressure on the tech start-up, though there is some speculation that Cisco might then snap up Nutanix. But Cisco has had success with its own hyperconvergence HyperFlex and may not see the need for Nutanix, making its stock a risky play.

Liquified natural gas refinery

Image source: Getty Images.

Tellurian

Last December, global oil giant Total (TTE -3.18%) bought a 23% stake in liquified natural gas specialist Tellurian, which is developing a $12 billion Louisiana LNG project called Driftwood. After Cheniere Energy (LNG 0.02%) paved the way for LNG export projects, there has been a wave of interest in replicating that success. In fact, Tellurian was founded by Charif Souki, who was ousted from his position of CEO at Cheniere in 2015.

So, why the reversal of fortunes? Up until the start of March, Tellurian had doubled in value in 2017, but after crashing 36% this month, it's barely above where it started the year. It turns out, Tellurian spooked the market by filing its intent to make a secondary offering of its stock that would represent approximately 10% of its $2.15 billion market capitalization. The Driftwood project is also apparently being called into question.

Still, the prospects for the export market look especially bright, as the world will need about 20 million tons more per year of LNG, and Tellurian CEO Meg Gentle says, "The U.S. will be the cheapest source of new LNG, so we believe a lot of that 100 million tons will come from the U.S."

Diluting shareholders always drags down a stock, but Tellurian may still be one to eventually bounce back if its project comes to fruition.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

NantHealth, Inc. Stock Quote
NantHealth, Inc.
NH
$0.42 (-2.42%) $0.01
Cisco Systems, Inc. Stock Quote
Cisco Systems, Inc.
CSCO
$41.96 (-0.62%) $0.26
Dell EMC Stock Quote
Dell EMC
EMC
TotalEnergies Stock Quote
TotalEnergies
TTE
$51.15 (-3.18%) $-1.68
Cheniere Energy, Inc. Stock Quote
Cheniere Energy, Inc.
LNG
$131.98 (0.02%) $0.03
NetApp, Inc. Stock Quote
NetApp, Inc.
NTAP
$64.22 (2.29%) $1.44
Hewlett Packard Enterprise Company Stock Quote
Hewlett Packard Enterprise Company
HPE
$12.83 (-1.00%) $0.13
Nutanix Stock Quote
Nutanix
NTNX
$15.04 (1.14%) $0.17
Tellurian Inc. Stock Quote
Tellurian Inc.
TELL
$2.89 (-3.34%) $0.10

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
316%
 
S&P 500 Returns
112%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 07/06/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.